Proposed fixes for important aspects of the cancer research infrastructure may help to fill in the cracks of a stressed foundation. Journal of the National Cancer Institute
A class of genetic mutations discovered in children with high-risk acute lymphoblastic leukemia gives hope for a new treatment approach; drugs targeting the defect are already in clinical development. Medscape Medical News
Fear of losing hospital revenues from hospitalizations due to chemotherapy toxicity translates into pressure to give patients with poor prognoses less-than-optimal chemotherapy. Medscape Medical News
Dr. Maurie Markman comments on a study in Lancet Oncology indicating that patients with NSCLC patients who have an EGFR mutation benefit more from gefitinib than from cisplatin/docetaxel. Medscape Genomic Medicine
Using Standards, Options and Recommendations methodology, the authors of this article established guidelines on central venous catheter (CVC)-associated thrombosis in cancer patients. Annals of Oncology
